ANIP ANI Pharmaceuticals
- 61.730
- +0.300+0.49%
- 61.730
- 0.0000.00%
ANI Pharmaceuticals News
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director TANNENBAUM RENEE P
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lalwani Nikhil
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 8-K: Current report
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 10-Q: Quarterly report
ANI Pharmaceuticals | 8-K: ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gassert Chad
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
ANI Pharmaceuticals | 8-K: Current report
Analysis
Price Target
No Data
